Nephros Inc. Files 8-K with Financial Updates
Ticker: NEPH · Form: 8-K · Filed: May 1, 2024 · CIK: 1196298
| Field | Detail |
|---|---|
| Company | Nephros Inc (NEPH) |
| Form Type | 8-K |
| Filed Date | May 1, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, exhibits, disclosure
Related Tickers: NEPH
TL;DR
NEPHROS INC filed an 8-K on May 1st, mostly about financial statements. No major news yet.
AI Summary
On May 1, 2024, Nephros Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating updates or disclosures related to the company's financial status. No specific financial figures or significant events were detailed in the provided excerpt.
Why It Matters
This filing provides an official update on Nephros Inc.'s financial statements and exhibits, which is crucial for investors to assess the company's current financial health and performance.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure of financial statements and exhibits, with no immediate indication of significant positive or negative events.
Key Players & Entities
- NEPHROS INC (company) — Registrant
- May 1, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 380 Lackawanna Place, South Orange, New Jersey 07079 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Nephros Inc.?
The primary purpose of this 8-K filing is to report on Regulation FD Disclosure and to provide Financial Statements and Exhibits.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is May 1, 2024.
In which state is Nephros Inc. incorporated?
Nephros Inc. is incorporated in Delaware.
What is the principal executive office address for Nephros Inc.?
The principal executive office address is 380 Lackawanna Place, South Orange, New Jersey 07079.
What is the Commission File Number for Nephros Inc.?
The Commission File Number for Nephros Inc. is 001-32288.
Filing Stats: 513 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-05-01 08:00:49
Key Financial Figures
- $0.001 — nge on which registered Common stock, $0.001 par value NEPH The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 36KB
- ex99-1.htm (EX-99.1) — 21KB
- ex99-1_001.jpg (GRAPHIC) — 315KB
- ex99-1_002.jpg (GRAPHIC) — 528KB
- ex99-1_003.jpg (GRAPHIC) — 267KB
- ex99-1_004.jpg (GRAPHIC) — 288KB
- ex99-1_005.jpg (GRAPHIC) — 320KB
- ex99-1_006.jpg (GRAPHIC) — 364KB
- ex99-1_007.jpg (GRAPHIC) — 196KB
- ex99-1_008.jpg (GRAPHIC) — 231KB
- ex99-1_009.jpg (GRAPHIC) — 288KB
- ex99-1_010.jpg (GRAPHIC) — 232KB
- ex99-1_011.jpg (GRAPHIC) — 249KB
- ex99-1_012.jpg (GRAPHIC) — 227KB
- ex99-1_013.jpg (GRAPHIC) — 234KB
- ex99-1_014.jpg (GRAPHIC) — 196KB
- ex99-1_015.jpg (GRAPHIC) — 254KB
- ex99-1_016.jpg (GRAPHIC) — 145KB
- ex99-1_017.jpg (GRAPHIC) — 256KB
- ex99-1_018.jpg (GRAPHIC) — 319KB
- ex99-1_019.jpg (GRAPHIC) — 270KB
- ex99-1_020.jpg (GRAPHIC) — 236KB
- ex99-1_021.jpg (GRAPHIC) — 242KB
- ex99-1_022.jpg (GRAPHIC) — 196KB
- ex99-1_023.jpg (GRAPHIC) — 214KB
- ex99-1_024.jpg (GRAPHIC) — 207KB
- ex99-1_025.jpg (GRAPHIC) — 329KB
- ex99-1_026.jpg (GRAPHIC) — 212KB
- ex99-1_027.jpg (GRAPHIC) — 40KB
- ex99-1_028.jpg (GRAPHIC) — 316KB
- ex99-1_029.jpg (GRAPHIC) — 285KB
- ex99-1_030.jpg (GRAPHIC) — 319KB
- ex99-1_031.jpg (GRAPHIC) — 319KB
- ex99-1_032.jpg (GRAPHIC) — 154KB
- 0001493152-24-017355.txt ( ) — 11588KB
- neph-20240501.xsd (EX-101.SCH) — 3KB
- neph-20240501_lab.xml (EX-101.LAB) — 33KB
- neph-20240501_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Nephros, Inc. Dated: May 1, 2024 By: /s/ Judy Krandel Judy Krandel Chief Financial Officer